Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjhemonc logo
VJRegenMed
Logo
  • Home (current)
  • Specialties
    Hematology
    Oncology
    Musculoskeletal Disorder
    Rare Disease
    Metabolic Disorder
    Cardiovascular Disease
    Ophthalmology
    Neurology
    Infectious Disease
    View all Specialties
  • Technologies
    Cell Therapy
    MSC
    iPSC
    Gene Therapy
    Genome Editing
    Extracellular Vesicles
    CAR-T Therapy
    TCR Therapy
    Tissue-Engineering & Biomaterials
    View all Technologies
  • Topics
    Treatment
    Immuno-Oncology
    Trial Updates
    Perspectives
    Manufacturing
    COVID-19
    View all Topics
  • Conferences
    ASH 2022
    TCT 2022
    Meeting on the Med 2022
    ICLE 2022
    Advanced Therapies Week 2022
    TERMIS 2021
    ESGCT 2021
    Meeting on the Mesa 2021
    Advanced Therapies 2021
    View all Conferences
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Technical University of Munich

Targeting neoantigens in multiple myeloma with CAR T-cell 5:56
Targeting neoantigens in multiple myeloma with CAR T-cell
Angela Krackhard • 6 Apr 2022
Moving CAR T-cell therapies to earlier lines of therapy in multiple myeloma 2:30
Moving CAR T-cell therapies to earlier lines of therapy in multiple myeloma
Angela Krackhard • 6 Apr 2022
Developing individualized cancer therapies with neoantigen-specific TCRs 4:27
Developing individualized cancer therapies with neoantigen-specific TCRs
Angela Krackhard • 6 Apr 2022
Improving immune-imaging tools to assess cancer immunotherapies 5:33
Improving immune-imaging tools to assess cancer immunotherapies
Angela Krackhard • 6 Apr 2022
Accelerating the identification of clinically relevant T cell therapies 2:17
Accelerating the identification of clinically relevant T cell therapies
Elvira D’Ippolito • 31 Mar 2022
Unanswered questions in developing engineered T cells for solid tumors 2:35
Unanswered questions in developing engineered T cells for solid tumors
Elvira D’Ippolito • 31 Mar 2022
Novel approaches in lymphocyte engineering 3:31
Novel approaches in lymphocyte engineering
Elvira D’Ippolito • 31 Mar 2022
Journal Pages
  • Specialties
  • Technologies
  • Topics
  • Conferences
Newsletter

Receive the latest news and videos from VJRegenMed via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJRegenMed logo
The content of VJRegenMed is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy